Clearbridge Investments LLC boosted its stake in MetLife, Inc. (NYSE:MET - Free Report) by 43.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,663,177 shares of the financial services provider's stock after acquiring an additional 1,723,461 shares during the quarter. Clearbridge Investments LLC owned about 0.82% of MetLife worth $463,701,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of MET. Retirement Wealth Solutions LLC acquired a new stake in MetLife during the 4th quarter valued at $32,000. Sierra Ocean LLC purchased a new position in MetLife in the 4th quarter valued at about $32,000. Graney & King LLC acquired a new stake in shares of MetLife during the fourth quarter valued at about $34,000. Values First Advisors Inc. purchased a new stake in shares of MetLife during the fourth quarter worth about $36,000. Finally, Golden State Wealth Management LLC acquired a new position in shares of MetLife in the fourth quarter worth about $44,000. Institutional investors and hedge funds own 94.99% of the company's stock.
Wall Street Analyst Weigh In
Several research firms have issued reports on MET. StockNews.com downgraded MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Cowen restated a "buy" rating on shares of MetLife in a research note on Friday, March 7th. BMO Capital Markets assumed coverage on shares of MetLife in a research note on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price objective on the stock. Barclays dropped their target price on shares of MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a research report on Friday, February 7th. Finally, JPMorgan Chase & Co. reduced their price target on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat, MetLife presently has a consensus rating of "Moderate Buy" and a consensus price target of $94.85.
View Our Latest Analysis on MetLife
MetLife Stock Performance
NYSE MET traded down $4.64 during trading hours on Thursday, hitting $77.85. The company had a trading volume of 1,849,243 shares, compared to its average volume of 3,279,725. MetLife, Inc. has a fifty-two week low of $67.30 and a fifty-two week high of $89.05. The firm has a market cap of $53.03 billion, a P/E ratio of 13.04, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The business has a fifty day simple moving average of $82.98 and a 200-day simple moving average of $83.01.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Equities analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were given a dividend of $0.545 per share. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.80%. MetLife's dividend payout ratio (DPR) is 36.52%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.